期刊文献+

肝癌门静脉癌栓相关小分子的比较蛋白质组学分析 被引量:8

Comparative proteome analysis of PVTT related small molecules
原文传递
导出
摘要 目的筛选肝细胞肝癌门静脉癌栓(PVTT)形成过程中起重要作用的低相对分子质量蛋白质标记物。方法选取肝癌门静脉癌栓和肝癌无癌栓患者原发瘤组织各12例,利用16%SDS—PAGE和Tris-Tricine系统进行双向电泳,得到小相对分子质量蛋白表达图谱,经Image Master软件对比分析后,基质辅助激光解析飞行时间质谱(MALDI—TOFMS/MS)对差异点进行鉴定。免疫印迹法对鉴定蛋白进行初步验证。结果无PVTT和PVTT的原发瘤组织间共检测到88个差异点,其中相对分子质量(MW)低于20×10^3的差异点有42个。与无PVTT组比较,PVTT组中有41个蛋白点表达上调(其中19个MW低于20×10^3),47个蛋白点表达下调(23个MW低于20×10^3)。经质谱鉴定共发现钙结合蛋白S100A11,脂肪酸结合蛋白-1等11种胶内差异小分子蛋白质。免疫印迹验证结果证实S100A11在有或无PVTT的原发瘤组织中的确存在表达差异。结论PVTT的原发瘤组织与无PVTT原发瘤组织中存在差异表达的低相对分子质量蛋白,推测肝癌侵袭转移性与多种差异蛋白相关,S100A11可能是其中一种。 Objective To screen low molecular weight protein biomarkers which played an important role during the course of portal vein tumor thrombi (PVTT) formation in hepatocellular carcinoma (HCC). Methods We first selected 2 groups ( each group had 12 cases) of primary tumor tissue from human HCC with or without PVTF. Then a stable and standard low MW ( 〈20 ×10^3) protein electrophoresis platform was sued by changing both SDS-PAGE gel concentration and components of electrophoretic buffer system in the second step of 2-DE. Using optimized 2-DE and MALDI-TOF MS/MS, differentially expressed proteomes were compared and studied in the 2 groups. By using Western blot, the results were i- dentified. Results Protein samples from PVTT group or non-PVTF group ran 2-DE for 3 times repeatedly under the same conditions. Eighty-eight differential spots were detected between primary tumor tissues of the two groups. Compared with non-PVTT group, there were 41 up-regulated spots (including 19 MW lower than 20 × 10^3 ) and 47 down-regulated spots in PVTT group ( including 23 MW lower than 20×10^3 ). Thirty-six spots were picked and redundancy was eliminated. Finally, I 1 significantly differential low MW proteins such as S100All and fat acid binding (FAB) protein etc were further identified by MALDI-TOF MS/MS. The results from Western blotting validation confirmed the differential expression of S100A11 in primary tumor tissue with PVTT or without PVTT. Conclusion The low MW protein profile of HCC primary tumor tissue with PVTT displayed obvious difference compared with HCC tissue without PVTT. The results indicated that the invasive and metastatic characteristic of HCC had relations with many differentially expressed proteins, including S100A11.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第2期181-183,共3页 Chinese Journal of Experimental Surgery
关键词 肝细胞 门静脉 蛋白质组学 Carcinoma,hepatocelluler Portal vein Proteomics
  • 相关文献

参考文献5

二级参考文献18

  • 1Fields S.Proteomics in genomeland.Science,2001,291:1221-1224.
  • 2Issaq HJ,Conrads TP,Prieto DA,et al.SELDI-TOF MS for diagnostic proteomics.Anal Chem,2003,75:148-155.
  • 3Tang ZY,Ye SL,Liu YK,et al.A decade's studies on metastasis of hepatocellular carcinoma.J Cancer Res Clin Oncol,2004,130:187-196.
  • 4Ye QH,Qin LX,Forgues M,et al.Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.Nat Med,2003,9:416-423.
  • 5Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg, 2001,233:379-384.
  • 6Yamada K, Soejima T, Sugimoto K, et al. Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Jpn J Clin Oncol, 2001, 31 : 147-152.
  • 7Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis analysis of 48 cases. Cancer, 2002, 95 : 588-595.
  • 8Satoshi I, Takashi O, Junji F, et al. Radioherapy after transcatheter arterial chemoembilization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol, 2002, 25 : 189-193.
  • 9Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in china Surgical techniques, indications, and outcomes. Langenbecks Arch Surg, 2005, 390:259-265.
  • 10Sugimoto C, Saito A, Kikuzato M, et al. Angioeehographic evaluation of tumor thrombi and the effect of transcatheter arterial embolization in patients with hepatoeellular carcinoma. J Gastroenterol, 2002, 37: 363-368.

共引文献89

同被引文献40

  • 1李炜,刘炳亚,李建芳,陈雪华,李琦,蔡劬,顾琴龙,朱正纲,林言箴.蛋白质组技术在胃癌相关标志物筛查中的应用[J].中华实验外科杂志,2006,23(10):1210-1212. 被引量:14
  • 2王秀梅,杰恩斯,马彦清,陈波,郭小进,阿力木太,哈那提,李锋,杨磊,秦江梅.新疆哈萨克族食管癌危险因素病例对照研究[J].中国公共卫生,2007,23(6):737-738. 被引量:33
  • 3Gourin CG,Terris DJ.Carcinoma of the hypopharynx.Surg Oncol Clin N Am,2004,13:81-98.
  • 4Lee KJ.Essential otolaryngology:head and neck surgery,Ninth Edition.New York:Mcgraw-hill Professional Publishing,2008:676-707.
  • 5Gourin CG,Xia ZS,Han Y,et al.Serum protein profile analysis in patients with head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg,2006,132:390-397.
  • 6Gourin CG,Moretz WH,Weinberger PM,et al.Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.Arch Otohryngol Head Neck Surg,2007,133:1125-1130.
  • 7Zhou L,Cheng L,Tao L,et al.Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.Acta Otolaryngol,2006,126:853-860.
  • 8王进峰(综述),华立新(审校).肾肿瘤的流行病学研究[J].国际泌尿系统杂志,2007,27(5):632-639. 被引量:6
  • 9Chua KY. Huangfu T, Liew LN. DNA vaccines and allergic diseases. Clin Exp Phamaco Physio1,2006 ,33 :546-550.
  • 10Takano M, Kikuchi Y, Asakawa T, et al. Identification of potential serm markers for endometrial cancer using protein expression profi- ling. J Cancer Res Clin Oncol,2010,136:475-481.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部